Pages that link to "Item:Q305603"

The following pages link to A cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q305603):

Displaying 8 items.

• A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications (Q669039) (← links)
• A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies (Q2104157) (← links)
• Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative (Q2116142) (← links)
• Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison (Q2192671) (← links)
• A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325) (← links)
• Modeling the effect of immunotherapies on human castration-resistant prostate cancer (Q2225975) (← links)
• Optimal control of variable-order fractional model for delay cancer treatments (Q2245845) (← links)
• MATHEMATICAL MODELING OF <i>IN-VIVO</i> TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS (Q4628893) (← links)